Hosted on MSN50m
Leerink Partners Downgrades Pliant Therapeutics (PLRX)
Fintel reports that on March 3, 2025, Leerink Partners downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for ...